Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private

BSE1265.55-17.1 (-1.33 %)

PREV CLOSE ( ) 1282.65

OPEN PRICE ( ) 1267.15

BID PRICE (QTY) 1265.30 (11)

OFFER PRICE (QTY) 1267.75 (1)

VOLUME 18070

TODAY'S LOW / HIGH ( )1244.60 1290.30

52 WK LOW / HIGH ( )610 1314.3

NSE1267.50-9.1 (-0.71 %)

PREV CLOSE( ) 1276.60

OPEN PRICE ( ) 1274.00

BID PRICE (QTY) 1267.50 (174)

OFFER PRICE (QTY) 1268.10 (10)

VOLUME 356028

TODAY'S LOW / HIGH( ) 1244.10 1292.10

52 WK LOW / HIGH ( )621 1311

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

1168.64

1078.64

858.96

834.9

Total Expenditure

995.34

989.13

788.36

779.03

PBIDT (Excl OI)

173.3

89.51

70.6

55.87

Other Income

11.55

7.22

0.44

3.77

Operating Profit

184.85

96.72

71.04

59.64

Interest

4.13

3.88

4.16

1.72

Exceptional Items

PBDT

180.72

92.84

66.88

57.92

Depreciation

89.71

72.58

69.23

68.13

Profit Before Tax

91.01

20.26

-2.35

-10.21

Tax

24.5

9.97

-3.73

-3.57

Provisions and contingencies

Profit After Tax

66.51

10.29

1.37

-6.64

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

66.51

10.29

1.37

-6.64

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

66.51

10.3

1.38

-6.64

Equity Capital

233.92

Face Value (IN RS)

Reserves

Calculated EPS

2.84

0.44

0.05

-0.28

Calculated EPS (Annualised)

11.37

1.76

0.23

-1.13

No of Public Share Holdings

6545097

% of Public Share Holdings

27.98

PBIDTM% (Excl OI)

14.82

8.29

8.21

6.69

PBIDTM%

15.81

8.96

8.27

7.14

PBDTM%

15.46

8.60

7.78

6.93

PBTM%

7.78

1.87

-0.27

-1.22

PATM%

5.69

0.95

0.16

-0.79

Notes

Risk Disclosures on Derivatives

Quarterly Results

TATVA CHINTAN PHARMA CHEM LTD.